Skip to main content
. 2021 Apr 13;11:598265. doi: 10.3389/fonc.2021.598265

Figure 2.

Figure 2

Forest plot of hazard ratio of progress-free survival in overall patients with all sites of positive activating EGFR mutation (A); in patients with positive exon 19 deletion mutation (B) and positive L858R point mutation (C).